SOBERANA, Cuba’s COVID-19 Vaccine Candidates: Dagmar García-Rivera PhD Director of Research, Finlay Vaccine Institute
On August 13, 2020, Cuba’s national regulatory agency, the Center for Quality Control of Medicines, Equipment and Medical Devices (CECMED), authorized clinical trials for SOBERANA 01—Cuba’s first vaccine candidate and the first from Latin America and the Caribbean. On August 24, parallel Phase I/II...
Guardat en:
| Publicat a: | MEDICC Review |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medical Education Cooperation with Cuba
2020
|
| Matèries: | |
| Accés en línia: | https://www.redalyc.org/articulo.oa?id=437565248013 https://www.redalyc.org/journal/4375/437565248013/ https://www.redalyc.org/journal/4375/437565248013/html/ https://www.redalyc.org/journal/4375/437565248013/437565248013.epub https://www.redalyc.org/journal/4375/437565248013/movil https://doi.org/10.37757/MR2020.V22.N4.11 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|